SAM
Senzar Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-907,203
| Closed | -$3.33M | – | 35 |
|
2016
Q3 | $3.33M | Sell |
907,203
-535,800
| -37% | -$1.97M | 0.86% | 31 |
|
2016
Q2 | $3.22M | Sell |
1,443,003
-173,197
| -11% | -$386K | 0.7% | 33 |
|
2016
Q1 | $3.36M | Buy |
1,616,200
+102,700
| +7% | +$214K | 0.67% | 30 |
|
2015
Q4 | $4.59M | Buy |
1,513,500
+137,913
| +10% | +$418K | 0.51% | 34 |
|
2015
Q3 | $3.4M | Buy |
1,375,587
+199,100
| +17% | +$492K | 0.49% | 29 |
|
2015
Q2 | $3.78M | Sell |
1,176,487
-839,800
| -42% | -$2.7M | 0.65% | 35 |
|
2015
Q1 | $7.2M | Sell |
2,016,287
-101,700
| -5% | -$363K | 1.75% | 19 |
|
2014
Q4 | $4.81M | Buy |
2,117,987
+43,587
| +2% | +$98.9K | 1.41% | 27 |
|
2014
Q3 | $4.03M | Buy |
2,074,400
+1,151,200
| +125% | +$2.23M | 1.18% | 22 |
|
2014
Q2 | $3.35M | Buy |
923,200
+501,800
| +119% | +$1.82M | 1.28% | 24 |
|
2014
Q1 | $1.64M | Buy |
421,400
+301,700
| +252% | +$1.17M | 0.87% | 17 |
|
2013
Q4 | $341K | Buy |
+119,700
| New | +$341K | 0.28% | 19 |
|